Nawal M. Boukli to HIV-1
This is a "connection" page, showing publications Nawal M. Boukli has written about HIV-1.
Connection Strength
1.406
-
Alvarez-Rivera E, Rodr?guez-Valent?n M, Boukli NM. The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells. Viruses. 2023 03 22; 15(3).
Score: 0.612
-
Rodr?guez-Valent?n M, L?pez S, Rivera M, R?os-Olivares E, Cubano L, Boukli NM. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response. J Immunol Res. 2018; 2018:8741698.
Score: 0.442
-
Sep?lveda-Torres LDC, Rishishwar L, Rogers ML, R?os-Olivares E, Boukli N, Jordan IK, Cubano LA. A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011. PLoS One. 2017; 12(5):e0177452.
Score: 0.102
-
Yang J, Hu D, Xia J, Liu J, Zhang G, Gendelman HE, Boukli NM, Xiong H. Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology. J Neuroimmune Pharmacol. 2013 Sep; 8(4):921-33.
Score: 0.077
-
Cubano LA, Cumba L, del Sep?lveda-Torres LC, Boukli N, R?os-Olivares E. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005. Bol Asoc Med P R. 2010 Jul-Sep; 102(3):13-7.
Score: 0.063
-
Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol. 2009 Mar; 4(1):129-39.
Score: 0.056
-
Cubano LA, Sep?lveda-Torres Ldel C, Sosa G, Boukli N, Robles R, Rodriguez JW, Guzm?n L, R?os-Olivares E. Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations. Ethn Dis. 2008; 18(2 Suppl 2):S2-132-6.
Score: 0.053